Request Free Sample
×
South America Anti Hypertensive Drugs Market
ID: MRFR/HC/54828-HCR
200 Pages
February 2026
South America Antihypertensive Drugs Market South America Antihypertensive Drugs Market Research Report: By Drug Class (Diuretics, ACE Inhibitors, Beta Blockers, Calcium Channel Blockers, Angiotensin II Receptor Antagonists), By Administration Route (Oral, Injectable, Transdermal), By Indication (Essential Hypertension, Secondary Hypertension, Hypertensive Crisis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) andBy Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035
Industry Developments
The South America Antihypertensive Drugs Market has seen significant developments recently. In September 2023, Pfizer launched a new formulation aimed at enhancing patient compliance in Brazil, reflecting the region's focus on improving chronic disease management. Merck and Co. announced partnerships with local health authorities to expand access to hypertension treatment in Argentina in August 2023, further highlighting the market's growth potential. A notable acquisition was reported in June 2023, when Bristol-Myers Squibb acquired a local biotech company specializing in hypertension therapies, strengthening its footprint in the South American market. Over the past two years, the market has been influenced by regulatory changes in Brazil and Colombia, promoting the importation of generic antihypertensive drugs. Furthermore, the total market valuation has shown a growth rate of approximately 5% annually, driven by an increasing prevalence of hypertension and rising healthcare investments in the region. Major players such as Novartis and Takeda are actively participating in Research and Development initiatives tailored to address the unique challenges posed by the South American demographic, which is crucial for the advancement of cardiovascular health in the region.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 4.36(USD Billion) |
| MARKET SIZE 2024 | 4.48(USD Billion) |
| MARKET SIZE 2035 | 6.0(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.691% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Novo Nordisk, Merck, Pfizer, AbbVie, GSK, Boehringer Ingelheim, BristolMyers Squibb, Novartis, Takeda, Eli Lilly, Sanofi, Amgen, Johnson & Johnson, Teva, AstraZeneca |
| SEGMENTS COVERED | Drug Class, Administration Route, Indication, Distribution Channel, Regional |
| KEY MARKET OPPORTUNITIES | Aging population growth, Increased prevalence of hypertension, Expanding healthcare infrastructure, Rising demand for combination therapies, Orthostatic hypertension treatments development |
| KEY MARKET DYNAMICS | aging population, increasing hypertension prevalence, rise in pharmaceutical investments, government health initiatives, growing awareness and education |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
Leave a Comment
FAQs
What is the expected market size of the South America Antihypertensive Drugs Market in 2024?
The South America Antihypertensive Drugs Market is expected to be valued at 4.48 USD Billion in 2024.
What will the market size be in 2035?
The market is projected to reach a valuation of 6.0 USD Billion by 2035.
What is the expected CAGR from 2025 to 2035 for the market?
The anticipated CAGR for the South America Antihypertensive Drugs Market from 2025 to 2035 is 2.691%.
Which region holds the largest share in the market by 2024?
Brazil is projected to hold the largest share of the market, valued at 1.6 USD Billion in 2024.
What is the market size for Diuretics in 2024?
The Diuretics segment is expected to be valued at 1.3 USD Billion in 2024.
Which major players are leading the South America Antihypertensive Drugs Market?
Key players in the market include Novo Nordisk, Merck, Pfizer, AbbVie, and GSK.
What is the market size for Beta Blockers in 2035?
By 2035, the Beta Blockers segment is projected to reach a valuation of 1.5 USD Billion.
How does the market size for Calcium Channel Blockers compare from 2024 to 2035?
Calcium Channel Blockers are expected to grow from 0.8 USD Billion in 2024 to 1.0 USD Billion in 2035.
What is the market size value for Argentina in 2024?
The market in Argentina is expected to be valued at 0.8 USD Billion in 2024.
What is the projected market value for Angiotensin II Receptor Antagonists by 2035?
The Angiotensin II Receptor Antagonists segment is anticipated to reach 0.55 USD Billion by 2035.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense